ARTICLE | Company News
Teva sales and marketing update
September 14, 2015 7:00 AM UTC
Teva launched Zecuity sumatriptan in the U.S. for the acute treatment of migraine with or without aura. The wholesale acquisition cost (WAC) for the transdermal patch delivering sumatriptan via ionto...